UPDATED Jun 26, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ACI | ₹691.65 | 2.9% | 28.0% | ₹85.1b | ₹757.20 | PE26.8x | E28.9% | 0.4% | Materials | ||
517522 | ₹590.40 | 6.1% | -29.2% | ₹29.9b | ₹772.00 | PE41.7x | E33.5% | 0.3% | Materials | ||
PLT | AU$0.80 | 0% | 138.8% | AU$138.5m | AU$1.30 | PS1.9x | E106.4% | n/a | Diversified Financials | ||
HHR | AU$0.007 | 0% | -69.6% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
CTT | AU$1.06 | -52.5% | -64.1% | AU$455.7m | AU$3.12 | PE20.8x | E26.7% | n/a | Retail | ||
A067310 | ₩20,750.00 | -9.2% | -5.0% | ₩974.6b | ₩34,000.00 | PB3.3x | E93.4% | 0.2% | Semiconductors | ||
A178320 | ₩27,750.00 | -2.1% | 43.9% | ₩1.5t | ₩36,666.67 | PE143.6x | E48.1% | 0% | Tech | ||
A179900 | ₩29,050.00 | -6.0% | 48.7% | ₩460.4b | ₩60,000.00 | PS22.9x | E122.7% | 0% | Tech | ||
A441270 | ₩8,890.00 | -1.1% | -1.2% | ₩322.8b | ₩11,500.00 | PE21.1x | E36.4% | n/a | Tech | ||
A204620 | ₩3,600.00 | -9.2% | -10.7% | ₩207.6b | ₩7,100.00 | PS1.9x | E72.4% | n/a | Commercial Services | ||
CRDO | US$29.71 | 1.7% | 68.8% | US$4.9b | US$28.75 | PS25.4x | E84.4% | n/a | Semiconductors | ||
688408 | CN¥92.76 | -6.4% | 11.8% | CN¥12.7b | CN¥89.23 | PE27.2x | E25.8% | 0.9% | Capital Goods | ||
VOW | NOK 6.25 | 6.8% | -48.9% | NOK 711.5m | NOK 11.00 | PB1.8x | E97.6% | 0% | Commercial Services | ||
4480 | JP¥3,585.00 | -2.2% | -31.5% | JP¥116.3b | JP¥5,800.00 | PE43.5x | E28.7% | n/a | Healthcare | ||
300181 | CN¥15.39 | -1.1% | 34.1% | CN¥10.4b | n/a | PE25.2x | E22.3% | 2.9% | Pharmaceuticals & Biotech | ||
GIG | NOK 29.70 | 5.5% | 19.0% | NOK 4.0b | NOK 45.03 | PE19.1x | E36.2% | n/a | Consumer Services | ||
KEBNI B | SEK 1.56 | -4.4% | 25.3% | SEK 424.1m | SEK 2.20 | PS4.6x | E90.4% | n/a | Tech | ||
ADOC | €8.16 | 15.1% | 106.1% | €120.2m | €9.70 | PS19.9x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
OSE | €6.05 | 3.4% | 80.6% | €131.6m | €7.15 | PS59.1x | E79.3% | n/a | Pharmaceuticals & Biotech | ||
CALTX | SEK 205.40 | 0.4% | 145.1% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
EH | US$13.64 | -6.0% | -5.7% | US$863.2m | US$24.98 | PS40x | E74.3% | n/a | Capital Goods | ||
HQU | S$0.43 | 1.2% | 97.7% | S$62.2m | n/a | PE11.3x | E21.1% | 3.7% | Capital Goods | ||
532900 | ₹77.75 | 8.2% | 209.5% | ₹66.6b | ₹95.00 | PE39x | E23.8% | 0.1% | Diversified Financials | ||
A089030 | ₩54,500.00 | 5.6% | 562.2% | ₩1.9t | ₩49,500.00 | PS13.4x | E118.2% | 0.2% | Semiconductors |